BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35589047)

  • 1. LukS-PV inhibits the proliferation of hepatocellular carcinoma cells by maintaining FOXO3 stability via the PI3K/AKT signaling pathway.
    Nie Z; Shi L; Song K; Xu X; Ding P; Lu B; Wu G; Ma X
    Cell Signal; 2022 Jul; 95():110357. PubMed ID: 35589047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression.
    Wang Z; Yu W; Qiang Y; Xu L; Ma F; Ding P; Shi L; Chang W; Mei Y; Ma X
    Mol Ther Oncolytics; 2020 Jun; 17():547-561. PubMed ID: 32637573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.
    Xu X; Ding P; Shi L; Wu G; Ma X
    BMC Cancer; 2022 Jun; 22(1):630. PubMed ID: 35676659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration via the TNNC1/PI3K/AKT Axis.
    Ma F; Wang Z; Qiang Y; Xu L; Ding P; Wang Y; Ma X
    Onco Targets Ther; 2020; 13():10221-10230. PubMed ID: 33116603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
    Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
    BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells.
    Bu S; Xie Q; Chang W; Huo X; Chen F; Ma X
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1531-7. PubMed ID: 23702031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells.
    Zhao CC; Yu WW; Qi YJ; Xu LF; Wang ZR; Qiang YW; Ma F; Ma XL
    Anticancer Drugs; 2020 Mar; 31(3):223-230. PubMed ID: 31789624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LukS-PV induces differentiation by activating the ERK signaling pathway and c-JUN/c-FOS in human acute myeloid leukemia cells.
    Dai C; Zhang C; Sun X; Pan Q; Peng J; Shen J; Ma X
    Int J Biochem Cell Biol; 2016 Jul; 76():107-14. PubMed ID: 27102414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of HepaCAM inhibits bladder cancer cell proliferation and viability through the AKT/FoxO pathway.
    Tang M; Zhao Y; Liu N; Chen E; Quan Z; Wu X; Luo C
    J Cancer Res Clin Oncol; 2017 May; 143(5):793-805. PubMed ID: 28229220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
    Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
    Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
    Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22871. PubMed ID: 34338398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LukS-PV induces cell cycle arrest and apoptosis through p38/ERK MAPK signaling pathway in NSCLC cells.
    Qiang Y; Ma F; Wang Z; Nie Z; Xu L; Ding P; Ma X
    Biochem Biophys Res Commun; 2020 Jan; 521(4):846-852. PubMed ID: 31708104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Houttuynia cordata Thunb Promotes Activation of HIF-1A-FOXO3 and MEF2A Pathways to Induce Apoptosis in Human HepG2 Hepatocellular Carcinoma Cells.
    Kim JM; Hwang IH; Jang IS; Kim M; Bang IS; Park SJ; Chung YJ; Joo JC; Lee MG
    Integr Cancer Ther; 2017 Sep; 16(3):360-372. PubMed ID: 27698266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
    Fei M; Lu M; Wang Y; Zhao Y; He S; Gao S; Ke Q; Liu Y; Li P; Cui X; Shen A; Cheng C
    Med Oncol; 2009; 26(2):178-85. PubMed ID: 18937079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits hepatocellular carcinoma development by inducing apoptosis and pyroptosis through regulating FOXO3.
    Shen Z; Zhou H; Li A; Wu T; Ji X; Guo L; Zhu X; Zhang D; He X
    Aging (Albany NY); 2021 Sep; 13(18):22120-22133. PubMed ID: 34546972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
    Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
    Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LukS-PV-Regulated MicroRNA-125a-3p Promotes THP-1 Macrophages Differentiation and Apoptosis by Down-Regulating NF1 and Bcl-2.
    Sun XX; Zhang SS; Dai CY; Peng J; Pan Q; Xu LF; Ma XL
    Cell Physiol Biochem; 2017; 44(3):1093-1105. PubMed ID: 29179212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ergosterol peroxide activates Foxo3-mediated cell death signaling by inhibiting AKT and c-Myc in human hepatocellular carcinoma cells.
    Li X; Wu Q; Bu M; Hu L; Du WW; Jiao C; Pan H; Sdiri M; Wu N; Xie Y; Yang BB
    Oncotarget; 2016 Jun; 7(23):33948-59. PubMed ID: 27058618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.